Search

everythinglearnresearchcommunity

for

Search:↓

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Platelet Rich Plasma (PRP) shows promise for hair growth, ulcer healing, and skin rejuvenation, but more research is needed for consistent results and it's not suitable for people with certain blood conditions.

There is no strong evidence that chemopreventive agents effectively prevent prostate cancer.

Platelet-rich plasma injections can effectively reduce hair thinning, especially in women.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

PRP can help regrow hair and improve hair density in people with androgenetic alopecia.

PRP shows promise for treating hair loss but needs more research.

A prostate cancer drug can lower the levels of a protein that the coronavirus uses to enter lung cells.

Platelet-rich plasma (PRP) was found not effective in treating male-patterned hair loss.

Laparoscopic surgery is safe and effective for colon cancer, with benefits like less blood loss and shorter hospital stays.

Platelet-rich fibrin (PRF) is better for natural healing, especially in dental and medical treatments.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Dutasteride effectively treats benign prostatic hyperplasia and may reduce prostate cancer risk.

PRP is an effective and safe treatment for hair loss in women.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

PRP is a simple, effective, and safe treatment for hair loss.

i-PRF and A-PRF are promising treatments for hair regrowth in androgenetic alopecia.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Platelet-rich plasma therapy improves hair growth and health in androgenetic alopecia better than some FDA-approved treatments.

PRP shows promise but lacks consistent evidence and regulation.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

A new method was developed to accurately measure enzyme activity related to prostate health.

The best speed for preparing platelet-rich plasma with PRPBAG® is 1800 rpm.